Patients with rheumatoid arthritis (RA) experience pain from inflammation, joint destruction, and neuropathy. Antidepressants may play a role among patients with RA and depression, fibromyalgia, or neuropathy to achieve desired outcomes. This commentary evaluated evidence for medications individually and identified important variables for future research. While we await the results of well-designed studies, a trial of duloxetine or milnacipran may be considered for patients with remnant pain and RA remission. Research is needed to evaluate the efficacy and safety of serotonin–norepinephrine reuptake inhibitors and tricyclic antidepressants in patients with RA and associated comorbid conditions.
HunterTMBoytsovNNZhangXSchroederKMichaudKAraujoAB.Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014. Rheumatol Int. 2017;37(9):1551-1557. doi:10.1007/s00296-017-3726-1.
2.
KrockEJurczakASvenssonCI. Pain pathogenesis in rheumatoid arthritis-what have we learned from animal models?Pain. 2018;159(suppl 1):S98-S109. doi:10.1097/j.pain.0000000000001333.
3.
WalshDAMcWilliamsDF.Mechanisms, impact and management of pain in rheumatoid arthritis. Nat Rev Rheumatol. 2014;10(10):581-592. doi:10.1038/nrrheum.2014.64.
4.
MatchamFRaynerLSteerSHotopfM.The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology. 2013;52(12):2136-2148. doi:10.1093/rheumatology/ket169.
5.
EnglbrechtMAltenRAringerM, et al. New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis—implications from the prospective multicenter VADERA II study. PLoS One. 2019;14(5). doi:10.1371/journal.pone.0217412.
6.
MatchamFGallowayJHotopfM, et al. The impact of targeted RA pharmacologic treatment on mental health. Arthritis Rheumatol. 2018;70:1377-1391. doi:10.1002/art.40565.
7.
RathbunAMHarroldLRReedGW.Temporal effect of depressive symptoms on the longitudinal evolution of RA disease activity. Arthritis Care Res. 2015;67(6):765-775. doi:10.1002/acr.22515.
8.
HustedJATomBDFarewellVTGladmanDD.Longitudinal study of the bidirectional association between pain and depressive symptoms in patients with psoriatic arthritis. Arthritis Care Res. 2012;64:758-765. doi:10.1002/acr.21602.
9.
SchieirOThombsBDHudsonM, et al. Symptoms of depression predict the trajectory of pain among patients with early inflammatory arthritis: a path analysis approach to assessing change. J Rheumatol. 2009;36(2):231-239. doi:10.3899/jrheum.080147.
10.
ten KloosterPMVeehofMMTaalEvan RielPLvan de LaarMA.Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment. Ann Rheum Dis. 2007;66(11):1485-1490. doi:10.1136/ard.2007.069765.
11.
ZhaoSSDuffieldSJGoodsonNJ.The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. Best Pract Res Clin Rheumatol. 2019;33(3):101423. doi:10.1016/j.berh.2019.06.005.
12.
KaeleyNAhmadSPathaniaMKakkarR.Prevalence and patterns of peripheral neuropathy in patients of rheumatoid arthritis. J Family Med Prim Care. 2019;8(1):22-26. doi:10.4103/jfmpc.jfmpc_260_18.
13.
AhmedSMaganTVargasMHarrisonASofatN.Use of the painDETECT tool in rheumatoid arthritis suggests neuropathic and sensitization components in pain reporting. J Pain Res. 2014;7:579-588. doi:10.2147/JPR.S69011.
14.
RichardsBL.Antidepressants for pain management in RA. Cochrane Database of Systematic Reviews. 2011;11:CD008920. doi:10.1002/14651858.CD008920.pub2.
15.
FiestKMHitchonCABernsteinCN, et al. Systematic review and meta-analysis of interventions for depression and anxiety in persons with rheumatoid arthritis. J Clin Rheumatol. 2017;23(8):425-434. doi:10.1097/RHU.0000000000000489.
16.
GraceEMBellamyNKassamYBuchananWW.Controlled, double-blind, randomized trial of amitriptyline in relieving articular pain and tenderness in patients with rheumatoid arthritis. Curr Med Res Opin. 1985;9(6):426-429. doi:10.1185/03007998509109614.
17.
BirdHBrogginiM.Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study. J Rheumatol. 2000;27(12):2791-2797.
18.
FrankRGKashaniJHParkerJC, et al. Antidepressant analgesia in RA. J Rheumatol. 1988;15(11):1632-1638.
19.
MacfarlaneJGJalaliSGraceEM.Trimipramine in rheumatoid arthritis: a randomized double-blind trial in relieving pain and joint tenderness. Curr Med Res Opin. 1986;10(2):89-93. doi:10.1185/03007998609110424.
20.
FowlerPDMacNeillASpencerDRobinsonETDickWC.Imipramine, rheumatoid arthritis and rheumatoid factor. Curr Med Res Opin. 1977;5(3):241-246. doi:10.1185/03007997709110172.
21.
LeeYCMassarottiEEdwardsRR, et al. Effect of milnacipran on pain in patients with RA with widespread pain: a randomized blinded crossover trial. J Rheumatol. 2016;43(1):38-45. doi:10.3899/jrheum.150550.
22.
ParkerJCSmarrKLSlaughterJR, et al. Management of depression in rheumatoid arthritis: a combined pharmacologic and cognitive-behavioral approach. Arthritis Rheum. 2003;49(6):766-777. doi:10.1002/art.11459.
23.
AshGDickensCMCreedFHJaysonMITomensonB.The effects of dothiepin on subjects with rheumatoid arthritis and depression. Rheumatology. 1999;38(10):959-967. doi:10.1093/rheumatology/38.10.959.
24.
Sarzi PuttiniPCazzolaMBoccassiniL, et al. A comparison of dothiepin versus placebo in the treatment of pain in rheumatoid arthritis and the association of pain with depression. J Int Med Res. 1988;16(5):331-337. doi:10.1177/030006058801600502.
25.
YoshiiIChijiwaT.Effectiveness of duloxetine for remnant pain relief in patients with rheumatoid arthritis despite remission. Drugs Ther Perspect. 2020;36(7):288-292. https://doi.org/10.1007/s40267-020-00739-5.
26.
Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. Am J Psychiatry. 2000;157(4 suppl):1-45.
27.
MacfarlaneGJKronischCDeanLE, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318-328. doi:10.1136/annrheumdis-2016-209724.
28.
BatesDSchultheisBCHanesMC, et al. A comprehensive algorithm for management of neuropathic pain. Pain Med. 2019;20(suppl 1):S2-S12. doi:10.1093/pm/pnz075.
